223. Primary membranoproliferative glomerulonephritis Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 243 / Drugs : 296 - (DrugBank : 84) / Drug target genes : 46 - Drug target pathways : 169
| Other names | Primary MPGN;Primary membranoproliferative glomerulonephritis type I;Primary MPGN I;Primary membranoproliferative glomerulonephritis type III;Primary MPGN III;Membranoproliferative glomerulonephritis;Glomerulonephritis;C3 glomerulonephritis;C3 glomerulopathy;IC-MPGN;MPGN; | ||
|---|---|---|---|
| Disease group | Kidney and urinary diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
440 patients Age distribution
 💬 |
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 2-2-10. Membranoproliferative glomerulonephritis; MPGN | ||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | - | ||